Assessment of cellular immune parameters in paediatric toxic shock syndrome: a report of five cases

Olivier Dauwalder1, Fabienne Venet, Etienne Javouhey

  • 1Centre National de Références des Staphylocoques, Faculté de Médecine Lyon Est, Université de Lyon, France. olivier.dauwalder@chu-lyon.fr

Insights

Toxic shock syndrome (TSS) and septic shock (SS) share symptoms, but TSS does not show the same immune suppression. TSS increases regulatory T cells (Treg), unlike septic shock, suggesting different immune responses.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pediatrics

Background:

  • Toxic shock syndrome (TSS) and septic shock (SS) present with similar clinical signs of severe inflammation.
  • Septic shock is characterized by delayed immunosuppression, including lymphopenia and reduced HLA-DR expression on monocytes.
  • Understanding the immune alterations in TSS is crucial for differentiating it from SS and guiding treatment.

Observation:

  • This study monitored five children diagnosed with TSS.
  • TSS cases were confirmed by clinical signs and specific Vbeta expansions linked to bacterial toxin genes.
  • Regulatory T cell (Treg) percentages were measured in TSS patients.

Findings:

  • Patients with TSS showed an increased percentage of circulating regulatory T cells (Treg).
  • Unlike septic shock, TSS did not exhibit lymphopenia or decreased HLA-DR expression on monocytes.
  • These findings suggest distinct immune alterations in TSS compared to SS, despite similar clinical presentations.

Implications:

  • The distinct immune profiles of TSS and SS indicate different underlying pathophysiological mechanisms.
  • Further research into Treg subsets in TSS is needed to elucidate the role of superantigens.
  • Differentiating immune responses in TSS and SS could lead to more targeted therapeutic strategies.